258 related articles for article (PubMed ID: 16434493)
1. Roles of protease-activated receptors in a mouse model of endotoxemia.
Camerer E; Cornelissen I; Kataoka H; Duong DN; Zheng YW; Coughlin SR
Blood; 2006 May; 107(10):3912-21. PubMed ID: 16434493
[TBL] [Abstract][Full Text] [Related]
2. Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells.
Camerer E; Kataoka H; Kahn M; Lease K; Coughlin SR
J Biol Chem; 2002 May; 277(18):16081-7. PubMed ID: 11850418
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
4. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia.
Pawlinski R; Pedersen B; Schabbauer G; Tencati M; Holscher T; Boisvert W; Andrade-Gordon P; Frank RD; Mackman N
Blood; 2004 Feb; 103(4):1342-7. PubMed ID: 14576054
[TBL] [Abstract][Full Text] [Related]
5. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
Taylor FB; Wada H; Kinasewitz G
Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
[TBL] [Abstract][Full Text] [Related]
6. Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis.
Cornelissen I; Palmer D; David T; Wilsbacher L; Concengco C; Conley P; Pandey A; Coughlin SR
Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18605-10. PubMed ID: 20930120
[TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries.
Hamilton JR; Moffatt JD; Frauman AG; Cocks TM
J Cardiovasc Pharmacol; 2001 Jul; 38(1):108-19. PubMed ID: 11444493
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis.
Pawlinski R; Mackman N
Crit Care Med; 2004 May; 32(5 Suppl):S293-7. PubMed ID: 15118533
[TBL] [Abstract][Full Text] [Related]
9. Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.
Posma JJ; Grover SP; Hisada Y; Owens AP; Antoniak S; Spronk HM; Mackman N
Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):13-24. PubMed ID: 30580574
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling.
Riewald M; Ruf W
J Biol Chem; 2005 May; 280(20):19808-14. PubMed ID: 15769747
[TBL] [Abstract][Full Text] [Related]
11. Redundancy and interaction of thrombin- and collagen-mediated platelet activation in tail bleeding and carotid thrombosis in mice.
Bynagari-Settipalli YS; Cornelissen I; Palmer D; Duong D; Concengco C; Ware J; Coughlin SR
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2563-9. PubMed ID: 25278288
[TBL] [Abstract][Full Text] [Related]
12. Delayed onset of inflammation in protease-activated receptor-2-deficient mice.
Lindner JR; Kahn ML; Coughlin SR; Sambrano GR; Schauble E; Bernstein D; Foy D; Hafezi-Moghadam A; Ley K
J Immunol; 2000 Dec; 165(11):6504-10. PubMed ID: 11086091
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia.
Schoergenhofer C; Schwameis M; Gelbenegger G; Buchtele N; Thaler B; Mussbacher M; Schabbauer G; Wojta J; Jilma-Stohlawetz P; Jilma B
Thromb Haemost; 2018 Jul; 118(7):1176-1184. PubMed ID: 29864779
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice.
Pawlinski R; Wang JG; Owens AP; Williams J; Antoniak S; Tencati M; Luther T; Rowley JW; Low EN; Weyrich AS; Mackman N
Blood; 2010 Aug; 116(5):806-14. PubMed ID: 20410508
[TBL] [Abstract][Full Text] [Related]
15. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists.
Hamilton JR; Frauman AG; Cocks TM
Circ Res; 2001 Jul; 89(1):92-8. PubMed ID: 11440983
[TBL] [Abstract][Full Text] [Related]
17. Protease-activated receptor signalling by coagulation proteases in endothelial cells.
Rezaie AR
Thromb Haemost; 2014 Nov; 112(5):876-82. PubMed ID: 24990498
[TBL] [Abstract][Full Text] [Related]
18. Chronological expression of PAR isoforms in acute liver injury and its amelioration by PAR2 blockade in a rat model of sepsis.
Jesmin S; Gando S; Zaedi S; Sakuraya F
Thromb Haemost; 2006 Dec; 96(6):830-8. PubMed ID: 17139380
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
[TBL] [Abstract][Full Text] [Related]
20. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.
Camerer E; Qazi AA; Duong DN; Cornelissen I; Advincula R; Coughlin SR
Blood; 2004 Jul; 104(2):397-401. PubMed ID: 15031212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
